{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T11:04:11Z","timestamp":1792407851828,"version":"4.4.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1016\/j.ahj.2015.04.011","type":"journal-article","created":{"date-parts":[[2015,4,18]],"date-time":"2015-04-18T00:25:24Z","timestamp":1429316724000},"page":"55-61","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Patient adherence to generic versus brand statin therapy after acute myocardial infarction: Insights from the Can Rapid Stratification of Unstable Angina Patients Suppress Adverse Outcomes with Early Implementation of the American College of Cardiology\/American Heart Association Guidelines Registry"],"prefix":"10.1016","volume":"170","author":[{"given":"Emily C.","family":"O'Brien","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa A.","family":"McCoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laine","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric D.","family":"Peterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracy Y.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ahj.2015.04.011_bb0005","first-page":"1383","article-title":"Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)","volume":"344","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2015.04.011_bb0010","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1016\/S0140-6736(00)03257-8","article-title":"Effects of pravastatin in 3260 patients with unstable angina: results from the LIPID study","volume":"356","author":"Tonkin","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2015.04.011_bb0015","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1056\/NEJM199610033351401","article-title":"The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators","volume":"335","author":"Sacks","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2015.04.011_bb0020","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1056\/NEJMoa040583","article-title":"Intensive versus moderate lipid lowering with statins after acute coronary syndromes","volume":"350","author":"Cannon","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2015.04.011_bb0025","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1016\/S0140-6736(02)11600-X","article-title":"PROspective Study of Pravastatin in the Elderly at Risk. Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial","volume":"360","author":"Shepherd","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2015.04.011_bb0030","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0140-6736(02)09327-3","article-title":"MRC\/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial","volume":"360","author":"Heart Protection Study Collaborative Group","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2015.04.011_bb0035","first-page":"476","article-title":"Retrospective observational assessment of statin adherence among subjects patronizing different types of community pharmacies in Canada","volume":"15","author":"Evans","year":"2009","journal-title":"J Manag Care Pharm"},{"key":"10.1016\/j.ahj.2015.04.011_bb0040","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1185\/03007990903192223","article-title":"Generic substitution: additional challenge for adherence in hypertensive patients?","volume":"25","author":"Hakonsen","year":"2009","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.ahj.2015.04.011_bb0045","first-page":"63","article-title":"Adherence and persistence with branded antidepressants and generic SSRIs among managed care patients with major depressive disorder","volume":"3","author":"Liu","year":"2011","journal-title":"Clinicoecon Outcomes Res"},{"key":"10.1016\/j.ahj.2015.04.011_bb0050","first-page":"450","article-title":"Medication adherence and use of generic drug therapies","volume":"15","author":"Briesacher","year":"2009","journal-title":"Am J Manag Care"},{"key":"10.1016\/j.ahj.2015.04.011_bb0055","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1001\/archinte.166.3.332","article-title":"The implications of choice: prescribing generic or preferred pharmaceuticals improves medication adherence for chronic conditions","volume":"166","author":"Shrank","year":"2006","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ahj.2015.04.011_bb0060","first-page":"457","article-title":"Measuring concurrent adherence to multiple related medications","volume":"15","author":"Choudhry","year":"2009","journal-title":"Am J Manag Care"},{"key":"10.1016\/j.ahj.2015.04.011_bb0065","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1185\/03007990903126833","article-title":"Good and poor adherence: optimal cut-point for adherence measures using administrative claims data","volume":"25","author":"Karve","year":"2009","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.ahj.2015.04.011_bb0070","series-title":"Department of Health and Human Services Health Resources and Services Administration Web site","author":"Area Resource File (ARF)","year":"2007"},{"key":"10.1016\/j.ahj.2015.04.011_bb0075","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1161\/01.CIR.88.4.1973","article-title":"Socioeconomic factors and cardiovascular disease: a review of the literature","volume":"88","author":"Kaplan","year":"1993","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2015.04.011_bb0080","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.ahj.2011.08.010","article-title":"Predicting long-term mortality in older patients after non-ST-segment elevation myocardial infarction: the CRUSADE long-term mortality model and risk score","volume":"162","author":"Roe","year":"2011","journal-title":"Am Heart J"},{"key":"10.1016\/j.ahj.2015.04.011_bb0085","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/0140-6736(90)92095-Y","article-title":"Treatment adherence and risk of death after a myocardial infarction","volume":"336","author":"Horwitz","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2015.04.011_bb0090","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1136\/bmj.38875.675486.55","article-title":"A meta-analysis of the association between adherence to drug therapy and mortality","volume":"333","author":"Simpson","year":"2006","journal-title":"BMJ"},{"key":"10.1016\/j.ahj.2015.04.011_bb0095","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1001\/jama.297.2.177","article-title":"Relationship between adherence to evidence-based pharmacotherapy and long-term mortality after acute myocardial infarction","volume":"297","author":"Rasmussen","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.ahj.2015.04.011_bb0100","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1056\/NEJMp1113112","article-title":"Generic atorvastatin and health care costs","volume":"366","author":"Jackevicius","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2015.04.011_bb0105","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1742-1241.2006.01217.x","article-title":"Evaluation of the cost savings and clinical outcomes of switching patients from atorvastatin to simvastatin and losartan to candesartan in a primary care setting","volume":"61","author":"Usher-Smith","year":"2007","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.ahj.2015.04.011_bb0110","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1016\/j.amjcard.2011.01.052","article-title":"Adherence to statins, subsequent healthcare costs, and cardiovascular hospitalizations","volume":"107","author":"Pittman","year":"2011","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ahj.2015.04.011_bb0115","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1111\/j.1365-2125.2004.02179.x","article-title":"Influence of socioeconomic status on the quality of prescribing in the elderly\u2014a population based study","volume":"58","author":"Odubanjo","year":"2004","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.ahj.2015.04.011_bb0120","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1001\/jama.279.18.1458","article-title":"Persistence of use of lipid-lowering medications: a cross-national study","volume":"279","author":"Avorn","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.ahj.2015.04.011_bb0125","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1345\/aph.1A044","article-title":"Influence of socioeconomic status on drug selection for the elderly in Canada","volume":"36","author":"Mamdani","year":"2002","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.ahj.2015.04.011_bb0135","doi-asserted-by":"crossref","first-page":"2514","DOI":"10.1001\/jama.2008.758","article-title":"Clinical equivalence of generic and brand-name drugs used in cardiovascular disease: a systematic review and meta-analysis","volume":"300","author":"Kesselheim","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.ahj.2015.04.011_bb0140","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1377\/hlthaff.28.2.546","article-title":"Patients' perceptions of generic medications","volume":"28","author":"Shrank","year":"2009","journal-title":"Health Aff (Millwood)"},{"key":"10.1016\/j.ahj.2015.04.011_bb0145","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1001\/archinternmed.2011.501","article-title":"\u201cTop 5\u201d lists top $5 billion","volume":"171","author":"Kale","year":"2011","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ahj.2015.04.011_bb0150","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1007\/s11606-007-0180-x","article-title":"Patients at-risk for cost-related medication nonadherence: a review of the literature","volume":"22","author":"Briesacher","year":"2007","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.ahj.2015.04.011_bb0155","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1111\/j.1525-1497.2004.30516.x","article-title":"Suboptimal statin adherence and discontinuation in primary and secondary prevention populations","volume":"19","author":"Ellis","year":"2004","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.ahj.2015.04.011_bb0160","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1001\/jama.298.1.61","article-title":"Prescription drug cost sharing: associations with medication and medical utilization and spending and health","volume":"298","author":"Goldman","year":"2007","journal-title":"JAMA"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870315002446?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870315002446?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T05:54:53Z","timestamp":1757570093000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002870315002446"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["S0002870315002446"],"URL":"https:\/\/doi.org\/10.1016\/j.ahj.2015.04.011","relation":{},"ISSN":["0002-8703"],"issn-type":[{"value":"0002-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2015,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Patient adherence to generic versus brand statin therapy after acute myocardial infarction: Insights from the Can Rapid Stratification of Unstable Angina Patients Suppress Adverse Outcomes with Early Implementation of the American College of Cardiology\/American Heart Association Guidelines Registry","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahj.2015.04.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}